Leverage • Ouro Fino
OFSA3
Ourofino Animal Health is a Brazilian animal health company dedicated to research, development, production and sale of veterinary drugs and vaccines. Its operations are divided into two main segments: Production Animals and Companion Animals. The Farm Animals segment focuses on cattle, especially in its antiparasitic portfolio, and serves the market through its own sales force and a wide reseller network. The Pet segment focuses on products for dogs and cats, marketed primarily to veterinary clinics and pet stores. The company has an industrial complex in Cravinhos (SP) and, in addition to its strong presence in the domestic market, has international operations focused on Latin America.
0,9
N.D./EBITDA
How many years of EBITDA are required to pay off the company's net debt, according to the official accounting standard IFRS16. As a market consensus, a value of up to 3 years of leverage is accepted for most companies.
61,4%
Debt/Equity
How much the company's debt represents in % in relation to its equity. As a market consensus, a value less than or equal to 1 is accepted, above that leverage can end up hurting the final result at some point.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!